Two Elsevier companies, MEDai, Inc. and Gold Standard, Inc., have introduced MTM 360, a complete medication therapy management (MTM) system. MTM 360 is projected to enable health plans, benefit sponsors and other payors to successfully meet Centers for Medicare and Medicaid Services' (CMS) expanded MTM programme requirements for 2010 and beyond. It is expected to aid their Medicare Part D business - from enrollment guidelines, medication reviews and interventions, to reporting and outcomes measurement. MTM 360 is claimed to combine the power of MEDai's Risk Navigator Guidelines and Gold Standard's MTM Exchange.
MEDai's Risk Navigator Guidelines incorporates more than 140 best practice guidelines developed by organisations like NCQA, AHRQ, PQA and others. The solution seeks to offer various advantages for Part D benefit sponsors, including the ability to modify or create guidelines to identify members for MTM programme participation; manage enrollment of targeted beneficiaries as per CMS requirements; monitor the medication compliance and gaps in therapy for members; and deliver relevant information to the point of care.
Gold Standard's MTM Exchange supplies customisable documentation and reporting of MTM services, as well as patient and provider communication. Users can perform comprehensive and targeted medication reviews; record consultations and interventions with patients and prescribers; view historical MTM and chart reviews for each member; assign and track follow-up actions to ensure continuity of care; and create on-demand reports per CMS Part D requirements.
Search for more such STM products in K-Store
Discuss this NEWS
